2) Platelet transfusion refractoriness
血小板输注无效
1.
Objective:To established HPA genotyping method and explored platelet transfusion refractoriness.
目的： 建立HPA基因型检测方法，探讨临床因HPA引起的血小板输注无效症的解决方案。
2.
33%(4/30) respectively,the rate of Platelet Transfusion Refractoriness(PTR) was 46.
33%(4/30);血小板输注无效率为43。
3.
Platelet transfusion refractoriness(PTR)is one kind of serious complication presenting in the clinical care hemorrhagic disease′s process,Because of their negative effects in clinical blood-transfusion,there were a great deal of studies on HPA during last few decades.
血小板输注无效(PTR)是临床治疗出血性疾病过程中出现的一种严重并发症,因其在临床输血实践中的负面作用,而备受关注。
3) platelet transfusions
血小板输注效率
4) Platelet transfusion refractoriness
血小板无效输注
1.
clinical Platelet transfusion refractoriness common is acute is leukemia patients.
输注血小板对于伴有血小板减少的急性白血病患者极为重要,临床上常有急性白血病患者血小板无效输注的发生,其原因复杂,包括非免疫相关因素免疫相关因素两个方面,治疗上以防治为主。
5) Platelet transfusion refractory(PTR)
血小板输注无效(PTR)
6) Platelet transfusion
血小板输注
1.
Detection of platelet antibody and its effect on platelet transfusion;
血小板抗体的检测及其对血小板输注效果的影响
2.
A reasearch on combined treatment of platelet transfusion and hormonotherapy for HELLP syndrome;
血小板输注联合激素治疗HELLP综合征
3.
The study was aimed to investigate the value of activated plasma clotting time(APCT)for estimating the efficacy of platelet transfusion therapy.
本研究探讨活化血浆凝固时间(APCT)对评价血小板输注疗效的价值,用血小板聚集凝血因子分析仪检测了20例血液病患者血小板输注前后APCT的变化,并与血小板计数增加校正指数(CCI)和实际血小板回收率(PPR)进行了对比研究。
补充资料：静脉输注
静脉输注
将药液输入或注射到静脉内的过程。参见"静脉注射"、"静脉输液法"和"静脉滴注"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条